Joint Formulary & PAD

Diroximal fumarate - Relapsing-remitting multiple sclerosis

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Capsules
Associated Icons :
BNF SPC
NHSE
NICE
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Diroximal fumarate
Indication :
Relapsing-remitting multiple sclerosis
Group Name :
Keywords :
Brand Names Include :
Vumerity
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Diroximal fumarate is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Relapsing-remitting multiple sclerosis.

Committee Recommendations (1)

01 Jul 22 - RSFT DTC

This drug has been included on the joint formulary having been agreed by the DTC of at least one Surrey Heartlands Acute Trust.

See “Formulary Status” to identify where this drug has been agreed for use.